Nguyen, Y., Flahault, A., Chavarot, N., Melenotte, C., Cheminant, M., Deschamps, P., Carlier, N., Lafont, E., Thomas, M., Flamarion, E., Lebeaux, D., Charlier, C., Rachline, A., Guérin, C., Ratiney, R., Touchard, J., Péré, H., Rozenberg, F., Lanternier, F., Arlet, J., Avouac, J., Boussaud, V., Guillemain, R., Vignon, M., Thervet, E., Scemla, A., Weiss, L., Mouthon, L., & , (2022). pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients. Clinical microbiology and infection, 28, 1654.e1–1654.e4. http://access.bl.uk/ark:/81055/vdc_100169755415.0x000022